Engage Bio
YC W22Potent, durable, and redosable non-viral genetic medicines
San Francisco, CA, USAFounded 202210 employeesengagebio.com
Team
10
Founded
2022
About
Engage Bio has developed Tethosomes, a new class of non-viral DNA which finally unleashes potent, durable, redosable, and scalable genetic medicine. In 2026 Engage was acquired by Eli Lilly.
No open roles at this time.
Similar Healthcare startups
ParcelBio
Elevated mRNA for transformative medicines.
Gene TherapySynthetic BiologyBiotech
Open Jobs —
Team 6
Founded 2024
Velorum Therapeutics
Breakthrough medicines unlocking the biology of heme
BiotechHealthcareTherapeutics
Open Jobs —
Team 5
Founded 2024
Granza Bio
Building programmable therapeutics for the immune system
Synthetic BiologyBiotechHealthcare
Open Jobs —
Team 7
Founded 2024
Abalone Bio
We create activating antibodies to treat diseases others can’t.
Machine LearningSynthetic BiologyTherapeutics
Open Jobs —
Team 14
Founded 2020